Respiratory Drug Delivery (RDD) Europe 2013 Announced
The Respiratory Drug Delivery (RDD) Europe 2013 scientific conference will take place in Berlin May 21-24, 2013. The event is jointly organized by RDD Online and Aptar Pharma and research, development, investigation, and marketing of existing and new therapies for drug delivery through the nose or lungs.
The meeting will begin with a plenary lecture titled “Biomarkers and Targeted Treatments for Small Airways Diseases – The Past, Present and Future” presented by Dr. D.S.Postma, M.D, Ph.D., Professor at the Department of Pulmonary Medicine and Tuberculosis, University Medical Centre Groningen, Groningen, The Netherlands.
Addressed during the symposium will be the following topics:
• Drug Development – New Drugs, Targets and Formulations
• Weighing the Evidence in Support of Bioequivalence
• Orphan drugs – Opportunities, Regulatory and Clinical Challenges
• Harmonizing the Clinical Requirements for LABA / ICS Combinations in the USA and Europe
• Designing Devices for the Marketplace
• Optimizing Formulation and Device Partnerships
RDD Europe 2013 also features an expanded high-profile exhibition showcasing the latest technologies and equipment in this exciting field. RDD conferences take place in both Europe and the USA in alternate years. More than 450 delegates are expected to attend the May 21-24 meeting to be held at the Intercontinental Hotel Berlin, Germany.
RDD Online manages the organization of Respiratory Drug Delivery meetings in the United States, and partners with Aptar Pharma to run RDD meetings in Europe. For more information, please visit www.rddonline.com.
Aptar Pharma is part of the Aptargroup family of companies, along with Aptar Beauty + Home and Aptar Food + Beverage. For more information, visit www.aptar.com/pharma.